Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Janssen launches online mental health video series

Healthy Minds will focus on brain disorder research and treatment

- PMLiVE

Liberation promotes Danielle Smith to account director

And Vicky Smith moves up to account executive

- PMLiVE

Celgene’s Abraxane authorised by Health Canada

Drug can now be used as first-line treatment for metastatic pancreatic cancer

- PMLiVE

Actelion partners with PatientsLikeMe on blood cancer research

Will create patient-reported outcomes tool for rare form of non-Hodgkin’s lymphoma

- PMLiVE

Wearing it well: the healthcare potential of wearable technology

For pharma the possibilities presented by wearable technology could be enormous

- PMLiVE

Roche’s Avastin gets new EU nod in ovarian cancer

Wins new approval for hard-to-treat platinum-resistant recurrent form of disease

- PMLiVE

FDA ‘must publish biosimilar naming guide soon’

US politicians push regulator to finalise guidance

- PMLiVE

Pfizer’s arthritis drug Enbrel widens its European licence

Gains new indication for early-stage inflammatory joint disease

Sanofi reception

Sanofi and Regeneron pay $67.5m to speed alirocumab review

Buy FDA priority review voucher from BioMarin

- PMLiVE

Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head

Moves to the Boston company from Onyx Pharmaceuticals

Fishawack buys UK med comms agency Facilitate

Dealis the Fishawack Group's third in just over a year

Roche Basel Switzerland

Roche pays $450m for ‘gene-silencing’ firm Santaris Pharma

Deal marks major return to the RNAi field it exited four years ago

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links